Skip to main navigation
Skip to search
Skip to main content
the University of Groningen research portal Home
Help & FAQ
English
Nederlands
Home
Profiles
Research units
Research output
Activities
Datasets
Press/Media
Projects
Prizes
Search by expertise, name or affiliation
Advancing Cancer Immunotherapy with Nanomedicine
Ghizlane Choukrani
Research output
:
Thesis
›
Thesis fully internal (DIV)
819
Downloads (Pure)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Advancing Cancer Immunotherapy with Nanomedicine'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Immunology and Microbiology
T Cell Activation
100%
Cancer Immunotherapy
100%
Immunoglobulin Domain
100%
Ecalectin
75%
Macrophage
50%
Immunotherapy
50%
Myeloid
50%
Antineoplastic Activity
50%
Autophagy
25%
T Cell
25%
Cancer Cell
25%
Biological Functions
25%
Antigen Specificity
25%
T Cell Receptor
25%
Neutrophil
25%
Phagocytosis
25%
Blocking Antibody
25%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Immunotherapy
100%
Nanomedicine
100%
Nanoparticle
83%
Immunoglobulin
66%
Drug Delivery System
50%
Ecalectin
50%
Calcium Carbonate
50%
Neoplasm
33%
Acute Myeloid Leukemia
33%
Anti-Inflammatory Drug
16%
Cytarabine
16%
Blocking Antibody
16%
Tumor Microenvironment
16%
Nanocarrier
16%
Biochemistry, Genetics and Molecular Biology
T Cell
100%
Cancer Immunotherapy
100%
Cell Activation
80%
Immunoglobulin Domain
80%
Galectin
60%
Macrophage
40%
Myeloid
40%
Antineoplastic Activity
40%
Autophagy
20%
Cancer Cell
20%
Monospecific Antibody
20%
Biological Functions
20%
T Cell Receptor
20%
Antigen Specificity
20%
Cytarabine
20%
Phagocytosis
20%
Keyphrases
V-domain Ig Suppressor of T Cell Activation
100%
Nanoimmunotherapy
75%